Dr.James Kim | Stemcells | Best Researcher Award
Bioprocess Scientist at PBS Biotech Inc, United States.
Dr. James Kim is a distinguished bioprocess scientist specializing in chemical and biomolecular engineering. Currently serving at PBS Biotech Inc., he focuses on advancing bioprocessing techniques, downstream analytics, and stem cell research. His expertise extends from his postdoctoral research at the University of Washington, where he pioneered exosome analysis for cancer diagnostics using nano-flow cytometry. During his Ph.D. at Ohio State University, he explored magnetic cell separation for clinical applications and studied hydrodynamic stress in bioreactors. Dr. Kim has collaborated with prestigious institutions, including the NIH, and has made significant contributions to regenerative medicine and biomanufacturing. His research seamlessly integrates fundamental scientific principles with industrial applications, reinforcing his reputation as a leading expert in biomedical engineering.
Education 
Dr. Kim earned his Ph.D. in Chemical and Biomolecular Engineering from Ohio State University (2015–2020) under the mentorship of Dr. Jeffrey Chalmers. His doctoral research focused on developing magnetic separation techniques for clinical applications and analyzing the impact of hydrodynamic stress on cell cultures in bioreactors. Before his doctoral studies, he completed a Bachelor of Science in Engineering (B.S.E.) in Chemical Engineering from the University of Michigan (2009–2015), graduating with cum laude honors. His undergraduate studies emphasized fluidics, flow cytometry, and bioprocess engineering, providing a solid foundation for his later research in cell separation, microfluidics, and assay development. Throughout his academic career, Dr. Kim demonstrated an interdisciplinary approach, integrating principles from engineering and biomedical sciences to drive innovation in biotechnology.
work Experience
With a diverse background in bioprocessing and analytical development, Dr. Kim currently works as a Bioprocess Scientist at PBS Biotech Inc., where he leads efforts in process scale-up, analytics development, and product testing for stem cell biomanufacturing. Prior to this, he conducted postdoctoral research at the University of Washington (2020–2023), where he played a pivotal role in advancing nano-flow cytometry for exosome-based cancer diagnostics while collaborating with leading industry partners like Beckman Coulter and the NIH. His Ph.D. research at Ohio State University (2015–2020) involved pioneering work in magnetic separation for anemia and cancer diagnostics, as well as characterizing hydrodynamic stress in bioreactors. His extensive experience bridges fundamental research with industrial applications, making significant contributions to the fields of regenerative medicine, precision diagnostics, and biomanufacturing.
Research Focus
Dr. Kim’s research centers on advancing bioprocessing strategies, optimizing bioreactor performance, and developing innovative cell separation techniques. His work in bioprocessing and bioreactor optimization includes modeling oxygen transfer for stem cell culture to improve scalability in regenerative medicine. He has significantly contributed to flow cytometry and exosome characterization, focusing on the standardization of single-molecule flow cytometry techniques for early-stage cancer diagnostics. Additionally, his expertise in magnetic cell separation has led to novel applications in anemia, sickle cell disease, and cancer diagnostics. His interdisciplinary research aims to bridge the gap between laboratory discoveries and scalable biomanufacturing, facilitating advancements in cell therapy, regenerative medicine, and precision diagnostics.
Awards & Honors🏆
Dr. Kim has received numerous accolades throughout his career, including a Poster Presentation Scholarship at the prestigious ECI: Cell Culture Engineering XVIII Conference in 2023, which awarded him $2,000 for his research contributions. In 2016, he earned another Poster Presentation Scholarship ($500) at the International Advanced Course on Regenerative Medicine Manufacturing. He has actively presented his work at multiple AIChE Annual Meetings between 2017 and 2019, receiving recognition for his oral and poster presentations. His collaborative research efforts with the NIH and industry leaders in the field of exosome flow cytometry have also been acknowledged, further solidifying his standing as an expert in bioprocess engineering and regenerative medicine..
Conclusion